181 related articles for article (PubMed ID: 27529513)
1. Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma.
Pottegård A; Schmidt SA; Olesen AB; Achacoso N; Van Den Eeden SK; Hallas J; Sørensen HT; Friis S; Habel LA
Br J Cancer; 2016 Sep; 115(7):895-900. PubMed ID: 27529513
[TBL] [Abstract][Full Text] [Related]
2. Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
Loeb S; Folkvaljon Y; Lambe M; Robinson D; Garmo H; Ingvar C; Stattin P
JAMA; 2015 Jun 23-30; 313(24):2449-55. PubMed ID: 26103029
[TBL] [Abstract][Full Text] [Related]
3. [Erectile dysfunction, PDE5A inhibitors and melanoma].
Schmutz JL
Ann Dermatol Venereol; 2015 Dec; 142(12):800-1. PubMed ID: 26293983
[No Abstract] [Full Text] [Related]
4. Melanoma, Viagra, and PDE5 Inhibitors: Proliferation and Metastasis.
Houslay MD
Trends Cancer; 2016 Apr; 2(4):163-165. PubMed ID: 28741569
[TBL] [Abstract][Full Text] [Related]
5. Melanoma and viagra: an unexpected connection.
Mitra D; Robinson KC; Fisher DE
Pigment Cell Melanoma Res; 2011 Feb; 24(1):16-8. PubMed ID: 21290790
[No Abstract] [Full Text] [Related]
6. Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database.
Lui JL; Shaw NM; Abbasi B; Hakam N; Breyer BN
Andrology; 2023 Oct; 11(7):1408-1417. PubMed ID: 36905319
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study.
Li WQ; Qureshi AA; Robinson KC; Han J
JAMA Intern Med; 2014 Jun; 174(6):964-70. PubMed ID: 24710960
[TBL] [Abstract][Full Text] [Related]
8. [Current role of sildenafil in the management of erectile dysfunction].
Akhvlediani ND; Matyukhov IP
Urologiia; 2018 May; (2):142-146. PubMed ID: 29901310
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink.
Matthews A; Langan SM; Douglas IJ; Smeeth L; Bhaskaran K
PLoS Med; 2016 Jun; 13(6):e1002037. PubMed ID: 27299522
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma.
Loeb S; Ventimiglia E; Salonia A; Folkvaljon Y; Stattin P
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 29117385
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Sildenafil in Men With Sexual Dysfunction and Spinal Cord Injury.
Ohl DA; Carlsson M; Stecher VJ; Rippon GA
Sex Med Rev; 2017 Oct; 5(4):521-528. PubMed ID: 28341580
[TBL] [Abstract][Full Text] [Related]
13. How sildenafil (Viagra
Lambert WC; Lambert MW; Ring CM; Gagna CE; Espinal-Mariotte JD; Schwartz RA
J Eur Acad Dermatol Venereol; 2018 May; 32(5):e202-e204. PubMed ID: 29194814
[No Abstract] [Full Text] [Related]
14. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.
Pattanaik S; Mavuduru RS; Panda A; Mathew JL; Agarwal MM; Hwang EC; Lyon JA; Singh SK; Mandal AK
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010060. PubMed ID: 30480763
[TBL] [Abstract][Full Text] [Related]
15. PDEI-5 for erectile dysfunction: a potential role in seizure susceptibility.
Matos G; Scorza FA; Cavalheiro EA; Tufik S; Andersen ML
J Sex Med; 2012 Aug; 9(8):2111-21. PubMed ID: 22613050
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation.
Scaglione F; Donde S; Hassan TA; Jannini EA
Clin Ther; 2017 Feb; 39(2):370-377. PubMed ID: 28139291
[TBL] [Abstract][Full Text] [Related]
17. A Case Report: Consecutive Cranial Neuropathies Following the Use of Phosphodiesterase-5 Inhibitors.
van Landingham SW; Singman EL
Am Orthopt J; 2015; 65():109-14. PubMed ID: 26564936
[TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial investigating treatment choice in Chinese men receiving sildenafil citrate and tadalafil for treating erectile dysfunction.
Bai WJ; Li HJ; Jin JJ; Xu WP; Sebastian S; Wang XF
Asian J Androl; 2017; 19(4):500-504. PubMed ID: 27101805
[TBL] [Abstract][Full Text] [Related]
19. Risk of Melanoma With Phosphodiesterase Type 5 Inhibitor Use Among Patients With Erectile Dysfunction, Pulmonary Hypertension, and Lower Urinary Tract Symptoms.
Shkolyar E; Li S; Tang J; Eisenberg ML
J Sex Med; 2018 Jul; 15(7):982-989. PubMed ID: 29884444
[TBL] [Abstract][Full Text] [Related]
20. [Sildenafil and increase in melanoma risk].
Saillen E
Rev Med Suisse; 2014 Jun; 10(433):1268-9. PubMed ID: 25004777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
